Group Chief Executive: | Greg Madison |
Independent Non-Executive Director: | Fabiana Lacerca Allen |
Independent Non-Executive Director: | Peter Llewellyn-Davies |
Independent Non-Executive Director: | Anders Lundstrom |
Non-Executive Chairman: | Hans-Peter Hasler |
Non-Executive Dir: | Christian Schweiger |
Address: | Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF |
Phone: | +44 (0) 191 511 8500 |
Website: | http://www.shieldtherapeutics.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYV81293 |
Currency | UK Pounds |
Share Price | 2.05p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 12.50 |
52 Week Low | 1.23 |
Volume | 690,953 |
Shares Issued | 782.06m |
Market Cap | £16.03m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:18 | 50,000 @ 2.01p |
15:31 | 18,000 @ 2.10p |
14:55 | 1,000 @ 2.00p |
14:55 | 8,000 @ 2.01p |
12:16 | 32,000 @ 2.10p |
You are here: research